GSK Investigational Site

Surry Hills, New South Wales 2010

0 studies enrolling now · 2 studies all time

What they study most

HIV Infections, Infection, Human Immunodeficiency Virus I

Studies at this site

• Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO) — Completed
• A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily — Completed